Drug General Information
Drug ID	D0QH6F
Former ID	DNC010615
Drug Name	4-methylaminomethyl-7-methoxycoumarin
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[531159]
Structure		Download 2D MOL 3D MOL
Formula	C12H13NO3
Canonical SMILES	CNCC1=CC(=O)OC2=C1C=CC(=C2)OC
InChI	1S/C12H13NO3/c1-13-7-8-5-12(14)16-11-6-9(15-2)3-4-10(8)11/h3-6,13H,7H2,1-2H3
InChIKey	GWMGUFTYUOYYQV-UHFFFAOYSA-N
PubChem Compound ID	8931837
Target and Pathway
Target(s)	Cytochrome P450 2D6	Target Info	Inhibitor	[531159]
KEGG Pathway	Metabolism of xenobiotics by cytochrome P450
	Drug metabolism - cytochrome P450
	Serotonergic synapse
Reactome	Xenobiotics
WikiPathways	Metapathway biotransformation
	Tamoxifen metabolism
	Oxidation by Cytochrome P450
	Vitamin D Receptor Pathway
	Aripiprazole Metabolic Pathway
	Fatty Acid Omega Oxidation
	Codeine and Morphine Metabolism
References
Ref 531159	J Med Chem. 2010 Oct 14;53(19):7129-39.Exploration of the amine terminus in a novel series of 1,2,4-triazolo-3-yl-azabicyclo[3.1.0]hexanes as selective dopamine D3 receptor antagonists.
Ref 531159	J Med Chem. 2010 Oct 14;53(19):7129-39.Exploration of the amine terminus in a novel series of 1,2,4-triazolo-3-yl-azabicyclo[3.1.0]hexanes as selective dopamine D3 receptor antagonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.